NYMOX PHARMACEUTICAL CORPORATION (NYMXF) Operating income 2015–2024
NYMOX PHARMACEUTICAL CORPORATION (NYMXF) annual operating income history from SEC filings — each fiscal year as reported.
-$4.3MFY2024 · since FY2015: -$17.7M → -$4.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -$4.3M | +48.7% |
| FY2023 | -$8.3M | -25.5% |
| FY2022 | -$6.7M | +46.8% |
| FY2021 | -$12.5M | -6.7% |
| FY2020 | -$11.7M | +12.0% |
| FY2019 | -$13.3M | -25.2% |
| FY2018 | -$10.6M | +19.6% |
| FY2017 | -$13.2M | -2.8% |
| FY2016 | -$12.9M | +27.1% |
| FY2015 | -$17.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice